Global Radiation Therapy Market to Reach USD 8.6 Billion by 2026 on Back of Product Approvals
|
By MedImaging International staff writers Posted on 18 Mar 2020 |

Illustration
The global radiation therapy market is projected to record a steady growth rate of 5.2% from 2018 to 2026 to reach USD 8.6 billion by 2026, driven by a surge in product approvals, increased expenditure on healthcare, high incidence of cancer, growing preference for non-invasive treatment procedures, technological advancements, and notable research and development activities.
These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.
A wave of therapeutic and diagnostic technologies is paving the way for higher growth in oncology, thus aiding radiation therapy and driving market growth. However, some key restraints are likely to impede market growth, including the high cost of treatment which makes it unaffordable for a large chunk of the population in the developing region, particularly in countries where healthcare cover is low. The market growth is also likely to be hampered by low awareness levels, as patients are sometime unaware of cancer cells wreaking havoc on their body until it is too late, leading to a late diagnosis. Radiation also takes a toll on the body and its side-effects can be difficult to tolerate for some patients, thus affecting the growth of the radiation therapy market.
Based on end-user, hospitals are expected to dominate the global radiation therapy market during the forecast period due to robust infrastructure with state of the art-equipment and services that are usually available. On the basis of type, the external beam radiation therapy segment is expected to account for the largest market share due to a stream of notable approvals and significant technological advancements.
Geographically, the Asia Pacific region is one of the biggest revenue generators in the global radiation therapy market, led by Japan, China, and India on the back of their rising levels of disposable income and improving healthcare infrastructure. In India, increased healthcare expenses and efforts to provide insurance cover to more people will contribute positively to the growth of the Asia Pacific radiation therapy market. Additionally, the large patient pool and increasing awareness about cancer symptoms and diagnosis will also fuel the growth of the radiation therapy market in the region.
Related Links:
Transparency Market Research
These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.
A wave of therapeutic and diagnostic technologies is paving the way for higher growth in oncology, thus aiding radiation therapy and driving market growth. However, some key restraints are likely to impede market growth, including the high cost of treatment which makes it unaffordable for a large chunk of the population in the developing region, particularly in countries where healthcare cover is low. The market growth is also likely to be hampered by low awareness levels, as patients are sometime unaware of cancer cells wreaking havoc on their body until it is too late, leading to a late diagnosis. Radiation also takes a toll on the body and its side-effects can be difficult to tolerate for some patients, thus affecting the growth of the radiation therapy market.
Based on end-user, hospitals are expected to dominate the global radiation therapy market during the forecast period due to robust infrastructure with state of the art-equipment and services that are usually available. On the basis of type, the external beam radiation therapy segment is expected to account for the largest market share due to a stream of notable approvals and significant technological advancements.
Geographically, the Asia Pacific region is one of the biggest revenue generators in the global radiation therapy market, led by Japan, China, and India on the back of their rising levels of disposable income and improving healthcare infrastructure. In India, increased healthcare expenses and efforts to provide insurance cover to more people will contribute positively to the growth of the Asia Pacific radiation therapy market. Additionally, the large patient pool and increasing awareness about cancer symptoms and diagnosis will also fuel the growth of the radiation therapy market in the region.
Related Links:
Transparency Market Research
Latest Industry News News
- GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
- GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
International Study Assesses AI for Prostate Cancer MRI Interpretation
Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read more
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read more
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read moreGeneral/Advanced Imaging
view channel
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more







